Aurobindo Pharma Ltd
AUROPHARMA (NSE)

654.90

38,373.12
Proj. ROE (%)
13.16
Proj. P/E (x)
12.36
Proj EV / EBITDA (x)
7.20
Proj. P/BV (x)
1.54
Proj. Revenue ( Cr.)
24,371.31

Stock View

BUY
Share on
The average score for Aurobindo Pharma Ltd stands at 7 against 6, three months back.

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
701.36
100 DMA ()
771.92
200 DMA ()
855.26
52 Weeks Range
620.50
1,063.90
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity